Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 41

Results For "distribution"

432 News Found

TLC partners Strides to launch Mucormycosis drug in India
News | May 28, 2021

TLC partners Strides to launch Mucormycosis drug in India

Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides


Cipla to market Roche's Antibody Cocktail in India
Policy | May 25, 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19


Glenmark receives ANDA approval for Icatibant Injection
News | May 25, 2021

Glenmark receives ANDA approval for Icatibant Injection

This marks Glenmark's first synthetic decapeptide injectable approval


Cipla launches Covid-19 RT-PCR test Viragen
News | May 21, 2021

Cipla launches Covid-19 RT-PCR test Viragen

This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19


Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency
News | May 21, 2021

Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency

Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.


Remdesivir production increased to 119 lakh vials per month
News | May 18, 2021

Remdesivir production increased to 119 lakh vials per month

Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60


Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine
News | May 18, 2021

Shilpa Medicare to produce 50 mn doses of Sputnik V Vaccine

Targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses from the date of start of commercial production


Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
News | May 18, 2021

Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities

Dr. Reddy's has the rights to distribute 250mn doses in India


Zydus Cadila entity to sell its India focused animal health business to a consortium
News | May 13, 2021

Zydus Cadila entity to sell its India focused animal health business to a consortium

The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,


Dr. Reddy's launches Ertapenem in US
News | May 12, 2021

Dr. Reddy's launches Ertapenem in US

The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health